Connect with us

Hi, what are you looking for?

DOGE0.070.84%SOL19.370.72%USDC1.000.01%BNB287.900.44%AVAX15.990.06%XLM0.080.37%
USDT1.000%XRP0.392.6%BCH121.000.75%DOT5.710.16%ADA0.320.37%LTC85.290.38%
THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & LifestyleTHE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle

Business

Business

Bristol-Myer’s New Melanoma Drug Receives Accelerated Approval

Bristol Myers Squibb Bristol Myers Squibb
Bristol Myers Squibb Bristol Myers Squibb

Bristol-Myers Squibb is one the leading pharmaceutical companies around the world, and they were just granted approval from the Food and Drug Administration to start releasing a new drug that will help patients with Melanoma.

Opdivo is the new drug being released by BMS, after being confirmed as a beneficial drug that will severely help patients who are diagnosed with Melanoma.

There is an estimated 76,100 people in the United States alone that suffer from this deadly skin disease, and a good majority of those infected with the disease may die at the hands of it. According to the FDA’s official website, Melanoma is the fifth most common type of cancer in the United States, and forms within the melanocyte cells, the cells that are responsible for developing skin pigmentation. Researchers have been trying to find new ways to cure this common disease, and there have been seven drugs approved the FDA for Melanoma since 2011.

The drug reportedly works by shrinking tumors on the skin for patients, and it goes after cancer cells. The drug was not going to be released just yet, but received accelerated approval after one third of the patients who were in trial with it showed signs of tumor shrinkage.

While Melanoma is a deadly disease, the approval of Opdivo has given a lot of people a chance at fighting this condition.

 

 


Comment Template

You May Also Like

Economy

Gaza Post-War Plan Disclosed by Israel’s PM Netanyahu Israeli Prime Minister Benjamin Netanyahu has outlined his vision for post-war Gaza, proposing that Israel would...

Politics

Finland blocks three Russian property acquisitions. On Wednesday, the Finnish Ministry of Defense announced that it had halted three real estate transactions, one of...

Politics

On Wednesday, the United States and its allies condemned North Korean missile strikes against Ukraine. Washington called the action disgusting, while Seoul branded Ukraine...

Economy

Japan’s Tohoku Electric will delay the nuclear reactor restart on construction works. Due to further safety building work, Japan’s Tohoku Electric Power (9506.T) said...

Notice: The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to our Privacy Policy and our Cookie Policy.

Ok